Targeted Agent Improves Survival in FLT3-Positive Acute Myeloid Leukemia

OS, EFS improved versus historical controls with addition of midostaurin to chemotherapy

Related Keywords

Germany ,United States ,Fox Chase Cancer Center ,Pennsylvania ,Philadelphia ,American ,Peter Abdelmessieh ,Charles Bankhead ,American Society Of Hematology ,University Hospital Ulm ,Study Group ,American Society ,Medpage Today ,